Comment
. 2002 Jun 15;20(12):2910; author reply 2910-1.
doi: 10.1200/JCO.2002.20.12.2910.
Comment on "Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols"
- PMID: 12065572
- DOI: 10.1200/JCO.2002.20.12.2910
Item in Clipboard
Comment
Comment on "Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols"
J Clin Oncol.
.
No abstract available
Comment on
-
Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.J Clin Oncol. 2002 Feb 1;20(3):776-90. doi: 10.1200/JCO.2002.20.3.776. J Clin Oncol. 2002. PMID: 11821461 Clinical Trial.
Similar articles
-
Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: the Rizzoli Institute experience.J Pediatr Hematol Oncol. 2008 Dec;30(12):908-12. doi: 10.1097/MPH.0b013e31817e4aee. J Pediatr Hematol Oncol. 2008. PMID: 19131777 Clinical Trial.
-
Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.Ann Surg Oncol. 2015 Apr;22(4):1080-7. doi: 10.1245/s10434-014-4154-z. Epub 2014 Oct 17. Ann Surg Oncol. 2015. PMID: 25323470 Clinical Trial.
-
Tumor size and prognosis in aggressively treated osteosarcoma.J Clin Oncol. 1996 Mar;14(3):848-58. doi: 10.1200/JCO.1996.14.3.848. J Clin Oncol. 1996. PMID: 8622033 Review.
-
Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.Acta Orthop Scand. 2001 Apr;72(2):167-72. doi: 10.1080/000164701317323426. Acta Orthop Scand. 2001. PMID: 11372948
-
Current treatment of high grade osteosarcoma of the extremity: review.J Chemother. 2001 Jun;13(3):235-43. doi: 10.1179/joc.2001.13.3.235. J Chemother. 2001. PMID: 11450880 Review.
Cited by
-
Radiosensitizing effects of c‑myc gene knockdown‑induced G2/M phase arrest by intrinsic stimuli via the mitochondrial signaling pathway.Oncol Rep. 2020 Dec;44(6):2669-2677. doi: 10.3892/or.2020.7806. Epub 2020 Oct 13. Oncol Rep. 2020. PMID: 33125136 Free PMC article.
-
hsa_circ_0085539 Promotes Osteosarcoma Progression by Regulating miR-526b-5p and SERP1.Mol Ther Oncolytics. 2020 Oct 4;19:163-177. doi: 10.1016/j.omto.2020.09.009. eCollection 2020 Dec 16. Mol Ther Oncolytics. 2020. PMID: 33209976 Free PMC article.
-
Metachronous Osteosarcoma, A Differential Diagnosis to be Considered in Children With Osteosarcoma: A Review of Literature and a Case From Our Center.J Pediatr Hematol Oncol. 2023 Apr 1;45(3):105-110. doi: 10.1097/MPH.0000000000002560. Epub 2022 Oct 17. J Pediatr Hematol Oncol. 2023. PMID: 36251795 Free PMC article. Review.
-
Circ0085539 Promotes Osteosarcoma Progression by Suppressing miR-526b-5p and PHLDA1 Axis.Front Oncol. 2020 Aug 26;10:1250. doi: 10.3389/fonc.2020.01250. eCollection 2020. Front Oncol. 2020. PMID: 32983961 Free PMC article.
-
Aberrant CXCR4 and β-catenin expression in osteosarcoma correlates with patient survival.Oncol Lett. 2015 Oct;10(4):2123-2129. doi: 10.3892/ol.2015.3535. Epub 2015 Jul 24. Oncol Lett. 2015. PMID: 26622806 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
